Iovance Biotherapeutics, Inc. Common Stock
$11.00
▲ +0.20
(+1.85%)
Volume: 12,589,468
· 2026-09-25
Loading…
RSI (14)
🧭 Style Verdicts
🚀
Momentum
87
- 21d momentum +36.1%
- MA aligned bullish
- RSI 74 overbought
🎯
Pullback
28
- Near upper Bollinger band
- +18.3% vs 20MA
💎
Value
50
- No fundamental data
Scores (0–100) derived from live technical & fundamental metrics. Not investment advice.
📐 Technicals
RSI(14)74.4
MACD+0.076
MA trendBullish
ATR5.25%
21d mom.+36.1%
63d mom.+158.8%
vs 20MA+18.3%
RVOL(20)0.93×
52w low · 2
52w high · 11
-1.2% from 52-week high
20d support 8
· resistance 11
Computed live from daily OHLCV · as of 2026-09-25
🏦 Fundamentals
Market cap$4.9B
PER—
PBR6.65
PSR15.05
EPS$-0.64
ROE-39.3%
ROA-31.6%
Dividend yield0.00%
Debt/Equity0.00
EV/EBITDA-18.43
| week | 1M | 3M | 6M | 1Y | YTD |
|---|---|---|---|---|---|
| +7.32% | +36.14% | +158.82% | +198.10% | +418.87% | +336.51% |
Valuation and profitability in USD, latest reported 2026-09-24. Period returns are price-based.
⚖️ AI Bull vs Bear
14d momentum +25.14%, daily vol 4.70%. Iovance Biotherapeutics, Inc. Common Stock sits in a bullish regime.
Derived from 14-day momentum and daily volatility on real OHLCV.
🗞 Related News
No recent news.